A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment
Conditions
- Mild Cognitive Impairment
Interventions
- DRUG: Choline Alfoscerate
- DRUG: Placebo
Sponsor
Chong Kun Dang Pharmaceutical
Collaborators